STOCK ALARM
PRO
SA
PRO
News
Screener
Alerts
Research
More
⌘K
⌘J
Pro
Sign In
Free Account
Themes
Teva Pharmaceutical Industries Limited
TEVA
NYSE
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
Financials
Growth
Insiders
Analysis
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Loading chart...
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$36.26B
+43.6%
P/E Ratio
23.74
+254.1%
P/S Ratio
1.94
+27.2%
ROE
19.31%
+163.3%
ROIC
14.69%
+1476.9%
FCF Yield
7.05%
+137.7%
Debt/Equity
2.20
-34.7%
Current Ratio
1.04
+5.7%
Interest Coverage
4.23x
+1499.2%
Per Share
Revenue/Share
$16.32
+11.5%
Net Income/Share
$1.33
+192.0%
Operating CF/Share
$2.71
+145.5%
Free CF/Share
$2.23
+237.2%
Cash/Share
$3.11
+6.5%
Book Value/Share
$6.91
+36.7%
Tangible Book/Share
$-10.37
+15.3%
Equity/Share
$6.91
+45.4%
Interest Debt/Share
$16.07
-4.8%
Valuation
Market Cap
$36.26B
+43.6%
Enterprise Value
$50.09B
+25.1%
P/E Ratio
23.74
+254.1%
P/S Ratio
1.94
+27.2%
P/OCF Ratio
11.70
-42.2%
P/FCF Ratio
14.18
-57.9%
P/B Ratio
4.58
-2.5%
P/TB Ratio
4.58
-2.5%
EV/Sales
2.68
+10.8%
EV/EBITDA
14.64
-71.6%
Profitability
Earnings Yield
4.21%
+164.9%
FCF Yield
7.05%
+137.7%
ROE
19.31%
+163.3%
ROIC
14.69%
+1476.9%
Return on Tangible Assets
7.28%
+187.8%
Capital Allocation
CapEx/OCF
17.50%
-56.2%
CapEx/Revenue
2.90%
-3.6%
CapEx/Depreciation
0.50
+6.3%
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity
2.20
-34.7%
Debt/Assets
0.43
-7.2%
Net Debt/EBITDA
4.04
-78.7%
Current Ratio
1.04
+5.7%
Interest Coverage
4.23x
+1499.2%
Income Quality
2.03
+418.8%
Efficiency
Days Sales Outstanding
72 days
+7.4%
Days Payables Outstanding
102 days
+7.7%
Days Inventory
128 days
-0.9%
Receivables Turnover
5.04x
-6.9%
Payables Turnover
3.57x
-7.1%
Inventory Turnover
2.85x
+0.9%
Special Valuations
Graham Number
$14.40
Graham Net-Net
$-21.76
+7.2%